Answers are grounded in this paper and cite their sources.
Mendelian randomization reveals gut microbiota influences colorectal neuroendocrine tumors, indicating potential mechanisms through inflammatory mediators.
The gut microbiota may influence the occurrence and development of colorectal neuroendocrine tumors (CR-NETs), with inflammatory mediators potentially playing an important intermediary role. However, the current research evidence is insufficient to support this view. In this study, we extracted SNP data from different Genome-Wide Association Study (GWAS) summary statistics. Using bidirectional two-sample Mendelian randomization (MR), two-step MR, and multivariable Mendelian randomization (MVMR) methods, we explored the causal relationship between gut microbiota, inflammatory proteins, and CR-NETs. Our study found that five types of gut microbiota (family Acidaminococcaceae, family Porphyromonadaceae, genus Oscillospira, genus Paraprevotella, genus Ruminococcaceae NK4A214 group) and five inflammatory mediators (C-C motif chemokine Ligand 4, C-C motif chemokine Ligand 23, TNF-related apoptosis-inducing ligand, C-X-C motif chemokine Ligand 5, Monocyte chemoattractant protein 2) have a causal relationship with CR-NETs. Additionally, C-C motif chemokine Ligand 23 (CCL23) mediated the causal effect of family Porphyromonadaceae on CR-NETs (with a mediation proportion of 6.3%), while C-C motif chemokine Ligand 4 (CCL4) mediated the causal effect of genus Ruminococcaceae NK4A214 group on CR-NETs (with a mediation proportion of 4.7%). There is a causal relationship between gut microbiota and inflammatory proteins in the development of CR-NETs, with CCL23 and CCL4 possibly playing a mediating role.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: